首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing
【24h】

An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing

机译:关于使用聚合物共混物改善通过可熔沉积模型(FDM)3D打印制备的药物固体分散体的可印刷性和调节药物释放的研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

FDM 3D printing has been recently attracted increasing research efforts towards the production of personalized solid oral formulations. However, commercially available FDM printers are extremely limited with regards to the materials that can be processed to few types of thermoplastic polymers, which often may not be pharmaceutically approved materials nor ideal for optimizing dosage form performance of poor soluble compounds. This study explored the use of polymer blends as a formulation strategy to overcome this processability issue and to provide adjustable drug release rates from the printed dispersions. Solid dispersions of felodipine, the model drug, were successfully fabricated using FDM 3D printing with polymer blends of PEG, PEO and Tween 80 with either Eudragit E PO or Soluplus. As PVA is one of most widely used polymers in FDM 3D printing, a PVA based solid dispersion was used as a benchmark to compare the polymer blend systems to in terms of processability. The polymer blends exhibited excellent printability and were suitable for processing using a commercially available FDM 3D printer. With 10% drug loading, all characterization data indicated that the model drug was molecularly dispersed in the matrices. During in vitro dissolution testing, it was dear that the disintegration behavior of the formulations significantly influenced the rates of drug release. Eudragit EPO based blend dispersions showed bulk disintegration; whereas the Soluplus based blends showed the 'peeling' style disintegration of strip-by strip. The results indicated that interplay of the miscibility between excipients in the blends, the solubility of the materials in the dissolution media and the degree of fusion between the printed strips during FDM process can be used to manipulate the drug release rate of the dispersions. This brings new insight into the design principles of controlled release formulations using FDM 3D printing. (C) 2016 Elsevier B.V. All rights reserved.
机译:FDM 3D打印最近吸引了越来越多的研究工作,以生产个性化的固体口服制剂。但是,市售的FDM打印机在可加工成几种类型的热塑性聚合物的材料方面受到极大限制,这些热塑性聚合物通常不是药学上认可的材料,也不是优化不良可溶性化合物剂型性能的理想选择。这项研究探索了使用聚合物共混物作为配方策略来克服这一可加工性问题,并从印刷分散液中提供可调节的药物释放速率。使用FDM 3D打印,PEG,PEO和Tween 80与Eudragit E PO或Soluplus的聚合物共混物,成功制备了模型药物非洛地平的固体分散体。由于PVA是FDM 3D打印中使用最广泛的聚合物之一,因此将基于PVA的固体分散体作为基准,以比较聚合物共混体系与可加工性。聚合物共混物表现出出色的可印刷性,适合于使用市售FDM 3D打印机进行加工。载药量为10%时,所有表征数据均表明模型药物分子分散在基质中。在体外溶出度测试中,亲爱的是制剂的崩解行为显着影响了药物的释放速率。 Eudragit EPO基共混物分散体显示出整体崩解性。而基于Soluplus的共混物则表现出逐条带状的“剥离”式崩解。结果表明,共混物中赋形剂之间的互溶性,材料在溶解介质中的溶解度以及在FDM过程中印刷条之间的融合度之间的相互作用可用于控制分散体的药物释放速率。这为使用FDM 3D打印的控释制剂的设计原理带来了新见解。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号